Image-1 (449d2ef9 3580 46c8 8fe5 5d81cb18e40f 01)
Levothyroxine Sodium Tablet
Product Images NDC 51655-985
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-985). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (51655 985 52 Master Bottle Label Approval Rev A 05 22)
This is a description of Levothyroxine Sodium Tablets, USP containing 25 mcg and packaged into 30 tablets. The NDC number is 51655-985-52 with a dosage instruction to see the package insert. The tablets should be stored at 25°C to not more than 30°C (77°F to 86°F) and kept in the original container with protection from light and moisture. This drug is Rx only and should be kept out of reach of children. The tablets contain Levothyroxine Sodium USP 25 meg (0.025mg). The drug was repackaged from 63180-965-XX and repackaged by Northwind Pharmaceuticals. The Lot number is 0000000000, and the GTIN number is 00351655986526. The S/N is also 000000000000000. The manufacturer is Lupin Pharmaceuticals, Inc. with a location in Indianapolis, IN 46203. The LCN# is 00, and revision A05/22.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
